By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



201, Avenue Président-Kennedy, Suite 3900

Montreal  Quebec  H4S 2C8  Canada
Phone: 514-940-3600 Fax: 514-940-3601


Caprion's Mission is centered on collaborating and partnering with pharmaceutical and biotech companies through proteomics and immune monitoring enabling the acceleration of precision medicine in drug development.

With a vision and deep understanding of the needs for complex immune monitoring in novel drug development, Caprion integrated ImmuneCarta (formerly known as National Immune Monitoring), with its established and proven proteomics service, ProteoCarta. Together, Caprion now offers a fully integrated and unique service offering to its partners.




CEO: Martin LeBlanc

CSO: Daniel Chelsky, Ph.D.

CFO: Normand Rivard, M.Sc.

Chief Business Officer: Carol Berry, MBA

Key Statistics

Ownership: Public

Web Site: Caprion
Symbol: CAPR

Company News
Caprion (CAPR) Acquires The Immune Monitoring Laboratory From ImmuneHealth 9/13/2016 6:52:51 AM
GHO Capital Announces Acquisition Of Caprion (CAPR) 7/20/2016 10:58:13 AM
Caprion (CAPR) To Present Two Posters At The Annual PEGS Conference In Boston 4/27/2016 8:18:01 AM
Caprion (CAPR) Co-authors Nature Publication Revealing Predictive Biomarkers Of Response To HBV Vaccines 1/26/2016 9:13:51 AM
Caprion (CAPR) Announces Agreement To In-License Xpresys® Lung From Indi® For Canadian Commercialization 2/3/2015 11:29:05 AM
Caprion (CAPR)/ImmuneCarta To Present At The GTC Bio Conference 1/27/2015 11:29:36 AM
Caprion (CAPR) Release: Data Reveals Plant-Made Flu Vaccine Demonstrates Ability To Elicit Strong T-Cell Immune Response 11/12/2014 8:55:28 AM
Caprion (CAPR) Receives Grant From The Michael J. Fox Foundation To Identify Parkinson’s Disease Biomarkers 9/9/2014 10:41:01 AM
Caprion (CAPR) To Present Immune Response Results From Phase 1 Study In Ovarian Cancer Patients At 2014 American Association for Cancer Research Annual Meeting 4/3/2014 3:39:39 PM